Mark Hopkins
Plus aucun poste en cours
Profil
Mark Hopkins worked as a Vice President-Intellectual Property at Threshold Pharmaceuticals, Inc. and as a Partner at Kilpatrick Townsend & Stockton LLP.
He graduated from John Marshall Law School (Georgia) with a graduate degree and from the University of California with a doctorate degree.
Anciens postes connus de Mark Hopkins
| Sociétés | Poste | Fin |
|---|---|---|
Kilpatrick Townsend & Stockton LLP
 Kilpatrick Townsend & Stockton LLP Miscellaneous Commercial ServicesCommercial Services Kilpatrick Townsend & Stockton LLP provides legal services. Its areas of expertise include intellectual property, labor and employment, litigation, financial restructuring, and commercial agreements. The firms professionals also provide Pro Bono work for education, child custody, and election protection. It serves clients in the advertising, energy, healthcare, real estate, technology and telecommunications industries. The company was founded in 2011 and is headquartered in Atlanta, GA. | Corporate Officer/Principal | - |
Threshold Pharmaceuticals, Inc.
 Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | Corporate Officer/Principal | - |
Formation de Mark Hopkins
| John Marshall Law School (Georgia) | Graduate Degree |
| University of California | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | Health Technology |
Kilpatrick Townsend & Stockton LLP
Kilpatrick Townsend & Stockton LLP Miscellaneous Commercial ServicesCommercial Services Kilpatrick Townsend & Stockton LLP provides legal services. Its areas of expertise include intellectual property, labor and employment, litigation, financial restructuring, and commercial agreements. The firms professionals also provide Pro Bono work for education, child custody, and election protection. It serves clients in the advertising, energy, healthcare, real estate, technology and telecommunications industries. The company was founded in 2011 and is headquartered in Atlanta, GA. | Commercial Services |
